Business Segment Information (Tables)

3 Months Ended

Apr. 02, 2016

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information

	Three Months Ended
	April 2,			March 28,
(In millions)	2016			2015
Revenues
Life Sciences Solutions	$	1,133.0		$	1,019.9
Analytical Instruments	759.3			727.4
Specialty Diagnostics	854.6			785.2
Laboratory Products and Services	1,724.6			1,513.4
Eliminations	(176.7		)	(127.1		)
Consolidated revenues	4,294.8			3,918.8
Segment Income (a)
Life Sciences Solutions	330.0			298.7
Analytical Instruments	111.7			121.7
Specialty Diagnostics	230.1			214.1
Laboratory Products and Services	258.2			222.1
Subtotal reportable segments (a)	930.0			856.6
Cost of revenues charges	(10.6		)	(0.6		)
Selling, general and administrative charges, net	(28.9		)	(7.6		)
Restructuring and other costs, net	(50.6		)	(32.0		)
Amortization of acquisition-related intangible assets	(322.0		)	(329.1		)
Consolidated operating income	517.9			487.3
Other expense, net (b)	(94.9		)	(105.3		)
Income from continuing operations before income taxes	$	423.0		$	382.0
Depreciation
Life Sciences Solutions	$	36.7		$	33.5
Analytical Instruments	9.6			9.3
Specialty Diagnostics	18.0			17.8
Laboratory Products and Services	29.8			26.6
Consolidated depreciation	$	94.1		$	87.2

(a) Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.

(b) The company does not allocate other expense, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information

	Three Months Ended
	April 2,			March 28,
(In millions)	2016			2015
Revenues
Life Sciences Solutions	$	1,133.0		$	1,019.9
Analytical Instruments	759.3			727.4
Specialty Diagnostics	854.6			785.2
Laboratory Products and Services	1,724.6			1,513.4
Eliminations	(176.7		)	(127.1		)
Consolidated revenues	4,294.8			3,918.8
Segment Income (a)
Life Sciences Solutions	330.0			298.7
Analytical Instruments	111.7			121.7
Specialty Diagnostics	230.1			214.1
Laboratory Products and Services	258.2			222.1
Subtotal reportable segments (a)	930.0			856.6
Cost of revenues charges	(10.6		)	(0.6		)
Selling, general and administrative charges, net	(28.9		)	(7.6		)
Restructuring and other costs, net	(50.6		)	(32.0		)
Amortization of acquisition-related intangible assets	(322.0		)	(329.1		)
Consolidated operating income	517.9			487.3
Other expense, net (b)	(94.9		)	(105.3		)
Income from continuing operations before income taxes	$	423.0		$	382.0
Depreciation
Life Sciences Solutions	$	36.7		$	33.5
Analytical Instruments	9.6			9.3
Specialty Diagnostics	18.0			17.8
Laboratory Products and Services	29.8			26.6
Consolidated depreciation	$	94.1		$	87.2

(a) Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.

(b) The company does not allocate other expense, net to its segments.